Holdings
Hillman Capital Management, Inc.
As of Jun 30, 2026, Hillman Capital Management, Inc. reported 47 positions worth US$127M. Largest: Cvs Health Corporation, Biogen Inc. and Warner Bros. Discovery, Inc. - Series A. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Cvs Health Corporation | 55,475 | US$5.74M | −11,987 | Jun 30, 2026 |
| Biogen Inc. | 23,993 | US$5.18M | −5,547 | Jun 30, 2026 |
| Warner Bros. Discovery, Inc. - Series A | 190K | US$5.07M | −6,323 | Jun 30, 2026 |
| Baxter International Inc. | 236K | US$5.03M | −11,288 | Jun 30, 2026 |
| International Flavors & Fragrances, Inc. | 62,875 | US$4.98M | −9,898 | Jun 30, 2026 |
| Gsk Plc | 92,383 | US$4.84M | −5,049 | Jun 30, 2026 |
| Carmax Inc | 91,385 | US$4.83M | −17,796 | Jun 30, 2026 |
| Boeing Company (the) | 21,574 | US$4.67M | −752 | Jun 30, 2026 |
| Zimmer Biomet Holdings, Inc. | 53,943 | US$4.64M | −1,757 | Jun 30, 2026 |
| The Kraft Heinz Company | 196K | US$4.64M | −4,646 | Jun 30, 2026 |